Skip to main content
MariMed Inc. logo

MariMed Inc. — Investor Relations & Filings

Ticker · MRMD CSE Manufacturing
Open in API
Filings indexed 142 across all filing types
Latest filing 2025-03-10 Regulatory Filings
Country CA Canada
Listing CSE MRMD

About MariMed Inc.

https://www.marimedinc.com/

MariMed Inc. is a leading multi-state cannabis operator (MSO) and brand innovator focused on the seed-to-sale lifecycle. The company develops, owns, and manages state-licensed facilities that serve as models of excellence for cultivation, production, and retail operations. MariMed is dedicated to creating high-quality, award-winning cannabis products designed to promote wellness and improve lives. Its diverse portfolio of branded products caters to a broad target market, including both wellness seekers and lifestyle enthusiasts. The company operates retail dispensaries that provide premium products and expert guidance. Furthermore, MariMed has expanded its business activities to include the production and sale of hemp-derived THC products, leveraging its established brands for new market penetration.

Recent filings

Filing Released Lang Actions
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Section 302 certification signed by the CFO. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report like a 10-K, must be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. FY 2024
2025-03-10 English
52-109F1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Sarbanes-Oxley Section 302 certification signed by the CEO/CFO. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report like a 10-K, should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive data. FY 2024
2025-03-10 English
Annual MD&A - English.pdf
Annual Report Classification · 1% confidence The document explicitly identifies itself as an 'Annual Report on Form 10-K' in the text (e.g., 'When used in this Annual Report on Form 10-K...'). It contains standard 10-K sections such as 'Item 5. Market for Registrant's Common Equity', 'Item 7. Management's Discussion and Analysis', and detailed descriptions of accounting policies. It is a comprehensive financial report rather than a summary or announcement. FY 2024
2025-03-10 English
Annual report on form 10-K - English.pdf
Annual Report Classification · 1% confidence The document is explicitly titled 'FORM 10-K' and contains standard SEC regulatory headers, including the registrant's name (MariMed Inc.), fiscal year-end date (December 31, 2024), and a table of contents corresponding to the requirements of an Annual Report. It is a comprehensive filing containing business descriptions, risk factors, and financial disclosures, confirming it is an Annual Report. FY 2024
2025-03-10 English
Audited annual financial statements – English.pdf
Annual Report Classification · 1% confidence The document contains detailed financial statements, including consolidated balance sheets, statements of operations, statements of stockholders' equity, and statements of cash flows for the years ended December 31, 2024 and 2023. It also includes an audit report from an independent registered public accounting firm. This content constitutes the core financial section of an annual report (10-K). FY 2024
2025-03-10 English
News release - English.pdf
M&A Activity Classification · 1% confidence The document is a press release announcing the completion of MariMed Inc.’s acquisition of First State Compassion Center. It describes an M&A transaction that has closed, fitting the category for M&A Activity (Code: TAR). There is no detailed financial reporting, earnings figures, or regulatory filing language beyond forward-looking statements typical of a corporate press release.
2025-03-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.